Weight loss

GLP-1 weight loss by telehealth

GLP-1 medicines such as semaglutide, and dual GLP-1/GIP medicines such as tirzepatide, are the prescriptions people ask about for weight loss. DoctorsHome explains how two telehealth brands describe those programs. A licensed clinician still decides whether any prescription is appropriate.

Gala markets compounded semaglutide and compounded tirzepatide, and a separate microdosing GLP-1/GIP tier.
Embody’s public homepage lists weekly compounded GLP-1 injections and weekly GLP-1/GIP injections.
Compounded products are not FDA-approved finished drugs. Brand-name options, when a program lists them, are a different product.

Affiliate link

Continue to Gala Health GLP-1

Joined GLP-1 weight-loss program, including the microdosing tier Gala markets beside its standard compounded option. You will leave DoctorsHome for the program’s own site. A clinician there decides whether to prescribe.

Program terms limit this offer to the United States and list all states. Gala’s own pages also say a licensed provider confirms eligibility where you live.

DoctorsHome is an independent publisher, not a medical practice. Some buttons are paid affiliate links. If you enroll through one, we may earn a commission. That does not change the price the program charges, and it is not a statement that a medication is right for you.

What these programs say they prescribe

Gala’s site lists compounded semaglutide, compounded tirzepatide (GLP-1/GIP), and brand-name semaglutide it labels as Ozempic. It also marks an oral Wegovy pill as coming soon. A May 12, 2026 Gala announcement describes two compounded tiers: GLP-1/GIP and microdosing GLP-1/GIP. Neither compounded tier is an FDA-approved finished drug.

Embody’s homepage describes one weekly injection and says a licensed clinician decides whether any medication is appropriate. The page states that compounded medicines have not been evaluated or approved by the FDA for safety, efficacy, or quality.

How a visit is described

Gala’s GLP-1 pages describe a health questionnaire of about five minutes, a review by a U.S.-licensed provider, and shipping from a licensed U.S. pharmacy if a prescription is written. Gala says it provides administrative and technology services and does not itself practice medicine. Its FAQ says medical services come from independent practices, including OpenLoop-affiliated groups.

Embody describes an online intake, a clinician review, and shipment after approval. Its FAQ says someone already on a GLP-1 can ask to transfer care by sharing proof of the current prescription, and that a provider decides whether the same dose is appropriate. Care coaching is optional and is not clinical care.

Price, without treating one number as the price

Gala publishes more than one starting price. The May 2026 announcement lists compounded GLP-1/GIP at $179 per month on a 3-month plan ($597) and microdosing GLP-1/GIP at $149 per month on a 3-month plan ($447). A compounded GLP-1 page on galahealth.co lists treatment from $179 per month on a yearly plan with all doses included. A FAQ on the same site says treatment can start at $69 per month. Those are not the same offer. Checkout is the price that applies.

On the day we reviewed joinem.co, Embody listed GLP-1 injections at a flat $49 per month and GLP-1/GIP injections at a flat $99 per month, and said the monthly price does not rise when the dose changes inside the same medication. The FAQ says price can still change with the plan length chosen at checkout (4, 12, 24, or 52 weeks). Older program materials have also described plans starting at $149 per month. Use the figure on the brand’s checkout.

What this page will not claim

Gala’s marketing cites study-style weight-loss percentages and patient stories. Those are the brand’s claims. DoctorsHome has not verified them, and they are not a prediction for any reader. GLP-1 medicines can cause nausea and other gastrointestinal effects, and they are not appropriate for everyone, including some people with a personal or family history of certain thyroid tumors. A clinician has to review that history.

Questions

Does DoctorsHome prescribe GLP-1 medication?

No. A button on this page can open a telehealth program’s own intake. The program’s clinician decides whether to prescribe. DoctorsHome does not take a medical history.

Are compounded GLP-1s FDA-approved?

No. Gala and Embody both say their compounded GLP-1 products are not FDA-approved finished drugs. A licensed compounding pharmacy prepares them when a clinician prescribes them. That is not the same as an FDA-approved product such as Wegovy.

Which states are excluded?

Gala’s GLP-1 program terms list the United States and all states, and its pages still say a provider confirms eligibility. Embody’s GLP-1 program terms exclude Louisiana. If you live in Louisiana, do not use an Embody GLP-1 offer. That offer is not linked on this site while approval is pending.

Keep reading

Ozempic and Wegovy are trademarks of their owners. DoctorsHome is not affiliated with or endorsed by those companies.

The joined affiliate button opens Gala Health’s GLP-1 tracking link. Embody’s GLP-1 offer is pending, so this page does not open an Embody tracking URL.

DoctorsHome publishes independent guides to telehealth programs. It is not a medical practice, clinic, pharmacy, or telehealth service. It does not diagnose, prescribe, or ship medication, and it is not a substitute for a licensed clinician.

Some buttons are paid affiliate links to Gala Health. If you enroll, we may earn a commission. That does not change the program’s price and it is not a medical endorsement. Pending programs are not linked. Compounded medicines are not FDA-approved finished drugs. Availability depends on the program and your state.

Nothing here is for emergencies. Call 911 for a medical emergency. If you are in a mental-health crisis, call or text 988.